《JPM 2023 Sage.pdf》由会员分享,可在线阅读,更多相关《JPM 2023 Sage.pdf(21页珍藏版)》请在三个皮匠报告上搜索。
1、J.P.Morgan Healthcare ConferenceJanuary 2023Sage Therapeutics 2023Safe Harbor Statement2 The slides presented today and the accompanying oral presentations contain forward-looking statements,which may be identified by the use of words such as“may,”“might,”“will,”“should,”“can,”,“expect,”“plan,”“anti
2、cipate,”“believe,”“estimate,”“project,”“intend,”“future,”“opportunity”,“goal”,“mission”,“potential,”“target”,or“continue,”and other similar expressions.Forward-looking statements in this presentation include statements regarding:our clinical development plans,including expected timelines for activit
3、ies and our expectations as to potential results;our belief that our NDA for zuranolone will be accepted and the possibility of priority review;the potential for approval and launch of zuranolone and potential timelines;our belief in the potential benefit and profile of zuranolone and in its potenti
4、al to be successful and to meet an unmet need in the treatment of MDD and PPD;the potential for commercialization of zuranolone and our commercialization plans,including plans to help enable access;our expectations as to the types of MDD patients who may benefit from zuranolone,if approved;the poten
5、tial for success of our other product candidates in various indications,including the potential profile and benefit of our other product candidates;our estimates as to the number of patients with disorders and diseases of interest to us and that we hope to help and the potential market for our produ
6、ct candidates,if approved;the goals,opportunity,mission and vision for business;and our views with respect our financial strength and potential value creation opportunities.These forward-looking statements are neither promises nor guarantees of future performance,and are subject to a variety of risk